| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a43ef275ae6f6fafc66975041eb60aa7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-924 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-25 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2010-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fdd7c6d6a4ba96dc3ed4cebd15ff0c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280545c082c24724c04947c4b9131262 |
| publicationDate |
2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2668079-T3 |
| titleOfInvention |
Compositions and methods to treat Gaucher's disease |
| abstract |
A method of identifying a subject as suitable for treatment with an alternative glucocerebrosidase enzyme, the method comprising: determining whether a neutralizing antibody to a glucocerebrosidase enzyme is present in a sample from a subject who is currently taking or has previously received the glucocerebrosidase enzyme for obtain a measured value of the antibody; comparing the measured value with a standard, where if the measured value is greater than the standard, it is identified that the subject has tested positive for the production of the antibodies; and selecting a subject for the alternative glucocerebrosidase enzyme on the basis that the subject has tested positive for antibody production. |
| priorityDate |
2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |